These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22855757)

  • 1. Evaluation of in-house ELISA using Trypanosoma cruzi lysate and recombinant antigens for diagnosis of Chagas disease and discrimination of its clinical forms.
    Longhi SA; Brandariz SB; Lafon SO; Niborski LL; Luquetti AO; Schijman AG; Levin MJ; Gómez KA
    Am J Trop Med Hyg; 2012 Aug; 87(2):267-71. PubMed ID: 22855757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme-linked immunosorbent assay for serological diagnosis of Chagas' disease employing a Trypanosoma cruzi recombinant antigen that consists of four different peptides.
    Ferreira AW; Belem ZR; Lemos EA; Reed SG; Campos-Neto A
    J Clin Microbiol; 2001 Dec; 39(12):4390-5. PubMed ID: 11724850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chagas disease-specific antigens: characterization of epitopes in CRA/FRA by synthetic peptide mapping and evaluation by ELISA-peptide assay.
    Bottino CG; Gomes LP; Pereira JB; Coura JR; Provance DW; De-Simone SG
    BMC Infect Dis; 2013 Dec; 13():568. PubMed ID: 24299278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of IgM antibodies to Trypanosoma cruzi urinary antigen in sera from patients with acute Chagas' disease.
    Corral RS; Altcheh JM; Freilij HL
    Int J Parasitol; 1998 Apr; 28(4):589-94. PubMed ID: 9602379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of serological tests to identify Trypanosoma cruzi infection in humans and determine cross-reactivity with Trypanosoma rangeli and Leishmania spp.
    Caballero ZC; Sousa OE; Marques WP; Saez-Alquezar A; Umezawa ES
    Clin Vaccine Immunol; 2007 Aug; 14(8):1045-9. PubMed ID: 17522327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterising the KMP-11 and HSP-70 recombinant antigens' humoral immune response profile in chagasic patients.
    Flechas ID; Cuellar A; Cucunubá ZM; Rosas F; Velasco V; Steindel M; Thomas Mdel C; López MC; González JM; Puerta CJ
    BMC Infect Dis; 2009 Nov; 9():186. PubMed ID: 19939275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immuno-enzymatic evaluation of the recombinant TSSA-II protein of Trypanosoma cruzi in dogs and human sera: a tool for epidemiological studies.
    Cimino RO; Rumi MM; Ragone P; Lauthier J; D'Amato AA; Quiroga IR; Gil JF; Cajal SP; Acosta N; Juárez M; Krolewiecki A; Orellana V; Zacca R; Marcipar I; Diosque P; Nasser JR
    Parasitology; 2011 Jul; 138(8):995-1002. PubMed ID: 21518468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of antibodies in sera from Chagas' disease patients using a Trypanosoma cruzi immunodominant recombinant antigen.
    Paranhos-Bacalla GS; Santos MR; Cotrim PC; Rassi A; Jolivet M; Camargo ME; Da Silveira JF
    Parasite Immunol; 1994 Mar; 16(3):165-9. PubMed ID: 8208589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standardization of micro-enzyme-linked immunosorbent assay (ELISA) and Western blot for detection of Trypanosoma cruzi antibodies using extracts from Mexican strains as antigens.
    Sánchez B; Monteón V; Reyes PA; Espinoza B
    Arch Med Res; 2001; 32(5):382-8. PubMed ID: 11578752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of different Trypanosoma cruzi antigens in the diagnosis of Chagas disease in patients with American cutaneous leishmaniasis from a co-endemic region in Argentina.
    Vega Benedetti AF; Cimino RO; Cajal PS; Juarez MDV; Villalpando CA; Gil JF; Marcipar IS; Krolewiecki AJ; Nasser JR
    Trop Med Int Health; 2013 Sep; 18(9):1103-1109. PubMed ID: 23837449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epitopes common to Trypanosoma cruzi and mammalian tissues are recognized by sera from Chagas' disease patients: prognosis value in Chagas disease.
    Laucella SA; de Titto EH; Segura EL
    Acta Trop; 1996 Dec; 62(3):151-62. PubMed ID: 9025983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunoenzymatic evaluation of the recombinant SAPA protein of Trypanosoma cruzi in naturally infected dogs].
    Cimino RO; Diosque P; López Quiroga IR; Gil JF; Nasser JR
    Rev Argent Microbiol; 2012; 44(3):177-81. PubMed ID: 23102466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reactivity of GST-SAPA antigen of Trypanosoma cruzi against sera from patients with Chagas disease and leishmaniasis].
    Gil J; Cimino R; López Quiroga I; Cajal S; Acosta N; Juarez M; Zacca R; Orellana V; Krolewiecki A; Diosque P; Nasser J
    Medicina (B Aires); 2011; 71(2):113-9. PubMed ID: 21550926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenicity and diagnostic potential of vaccine candidates in human Chagas disease.
    Gupta S; Wan X; Zago MP; Sellers VC; Silva TS; Assiah D; Dhiman M; Nuñez S; Petersen JR; Vázquez-Chagoyán JC; Estrada-Franco JG; Garg NJ
    PLoS Negl Trop Dis; 2013; 7(1):e2018. PubMed ID: 23350012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High sensitivity and reproducibility of in-house ELISAs using different genotypes of Trypanosoma cruzi.
    Caballero E Z; Correa R; Nascimento MS; Villarreal A; Llanes A; Kesper N
    Parasite Immunol; 2019 Jul; 41(7):e12627. PubMed ID: 30908676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of chimeric proteins in the serological diagnosis of chronic chagas disease - a Phase II study.
    Santos FL; Celedon PA; Zanchin NI; de Souza WV; da Silva ED; Foti L; Krieger MA; Gomes YM
    PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005433. PubMed ID: 28273127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune reactivity to Trypanosoma cruzi chimeric proteins for Chagas disease diagnosis in immigrants living in a non-endemic setting.
    Dopico E; Del-Rei RP; Espinoza B; Ubillos I; Zanchin NIT; Sulleiro E; Moure Z; Celedon PAF; Souza WV; da Silva ED; Gomes YM; Santos FLN
    BMC Infect Dis; 2019 Mar; 19(1):251. PubMed ID: 30871504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serodiagnosis of chronic and acute Chagas' disease with Trypanosoma cruzi recombinant proteins: results of a collaborative study in six Latin American countries.
    Umezawa ES; Luquetti AO; Levitus G; Ponce C; Ponce E; Henriquez D; Revollo S; Espinoza B; Sousa O; Khan B; da Silveira JF
    J Clin Microbiol; 2004 Jan; 42(1):449-52. PubMed ID: 14715803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trypanosoma cruzi recombinant complement regulatory protein: a novel antigen for use in an enzyme-linked immunosorbent assay for diagnosis of Chagas' disease.
    Meira WS; Galvão LM; Gontijo ED; Machado-Coelho GL; Norris KA; Chiari E
    J Clin Microbiol; 2002 Oct; 40(10):3735-40. PubMed ID: 12354873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance Assessment of a Trypanosoma cruzi Chimeric Antigen in Multiplex Liquid Microarray Assays.
    Santos FLN; Celedon PAF; Zanchin NIT; Leitolis A; Crestani S; Foti L; de Souza WV; Gomes YM; Krieger MA
    J Clin Microbiol; 2017 Oct; 55(10):2934-2945. PubMed ID: 28724556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.